Illumina Developing Avantome Sequencing for Clinical Applications

The company eventually plans to obtain 510(k) clearance from the US Food and Drug Administration for the platform it is developing, according to the company's president and CEO.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.